Clinical activity of pazopanib in metastatic extraosseous Ewing sarcoma

Clinical activity of pazopanib in metastatic extraosseous Ewing sarcoma

We report a response to pazopanib in a 69-year-old man with heavily pre-treated metastatic extraosseous Ewing sarcoma in addition to molecular profiling of his tumor. To our knowledge, this case is the earliest to demonstrate activity of an oral multi-targeted kinase inhibitor in Ewing sarcoma. This...

Full description

Bibliographic Details
Main Authors: Steven Attia, Scott H. Okuno, Steven I. Robinson, Nicolas P. Webber, Daniel J. Indelicato, Robin L. Jones, Sanjay P. Bagaria, Courtney Sherman, Kevin R. Kozak, Cherise M. Cortese, Thomas MacFarland, Jonathan C. Trent, Robert G. Maki
Format: Article
Language:English
Published: SAGE Publishing 2015-05-01
Series:Rare Tumors
Subjects:
Ewing
sarcoma
pazopanib
Online Access:http://www.pagepress.org/journals/index.php/rt/article/view/5992

Internet

http://www.pagepress.org/journals/index.php/rt/article/view/5992

Similar Items